Selective Serotonin Reuptake Inhibitors (SSRIs) have demonstrated efficacy in treating certain forms of obsessive-compulsive disorder and depression, yet the exact mechanisms by which they operate remain unclear. Current understanding indicates that SSRIs do not immediately affect serotonin levels but may influence brain plasticity, as evidenced by changes in brain-derived neurotrophic factor with prolonged use. Importantly, research is challenging the notion that depression results from a simple serotonin deficiency, suggesting that the 'chemical imbalance' theory is an oversimplification of a complex condition. Despite SSRIs' effectiveness in certain populations, understanding their mechanisms continues to be a significant area of inquiry and debate within the field of psychiatry.

Get the Snipd
podcast app

Unlock the knowledge in podcasts with the podcast player of the future.
App store bannerPlay store banner

AI-powered
podcast player

Listen to all your favourite podcasts with AI-powered features

Discover
highlights

Listen to the best highlights from the podcasts you love and dive into the full episode

Save any
moment

Hear something you like? Tap your headphones to save it with AI-generated key takeaways

Share
& Export

Send highlights to Twitter, WhatsApp or export them to Notion, Readwise & more

AI-powered
podcast player

Listen to all your favourite podcasts with AI-powered features

Discover
highlights

Listen to the best highlights from the podcasts you love and dive into the full episode